Home -> Law Blog Directory -> Intellectual Property Law Blogs -> IPKat
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: IPKatAzzurri take aim at "creaking" patent system
By Johanna Gibson, David Pearce, Jeremy Phillips and Ilanah Simon.
Here's a letter from Sergio Dompé (chairman of the Italian pharmaceuticals industry association Farmindustrìa), which had the good fortune to be published in the Financial Times last Friday, 9 July [with the IPKat's comments, as usual, in red]. Tongue-tied troubles over patentsSir, Michel Barnier, the European commissioner for the internal market, has proposed limiting the ?official? languages for the filing of European patents to just three: English, French and German, thereby excluding Spanish and Italian. The proposal has of course given rise to the obvious national polemics, but rather misses the point.
As chairman of the Italian pharmaceutical manufacturers association Farmindustria ? a group deeply involved in research and in the filing of patents ? I must observe that the cost of translating these filings is the least of our problems [this isn't surprising if you consider the size and spending power of the businesses associated with Farmindustria]. It is the patent system itself that is creaking and is steadily less able to defend and reward the intellectual property that it is supposed to protect [Fact? assertion? Can any reader substantiate this? And is it the patent system which is at fault, or its erosion by competition authorities?]. This vulnerability is the real risk.
As for the languages, if as is stated the purpose of this exercise is to reduce our translation costs, then logic would suggest that the most effective solution would be to standardise on a single language [This has been suggested, but not everyone warms to it. Why, some souls even thought it would be a good idea to make Italian an official language for Community trade mark and design administration through OHIM].
If this cannot be English for reasons of grandeur and national sentiment in countries more influential at the European level than Italy, then I suggest we might want to settle on Star Trek?s Klingon or the artificial language recently invented for the film Avatar".This is the response on behalf of Chartered Institute of Patent Attorneys president Alasdair Poore, which was not selected for publication:
"Sir, Instead of putting himself through the hassle of learning a difficult language such as Klingon or Na?vi (?Tongue-tied over patents?, July 9 2010) Sergio Dompé could save himself a lot of trouble: Latin perhaps, the educated lingua franca in Europe for many centuries.However, it is wrong to belittle the costs of translation. For all businesses, including pharma, they add up; and for small businesses they can be prohibitive, and certainly discourage access to the European system. Of course, Europe could just do what the world?s scientific and industrial communities already do: put issues of perceived grandeur and national status to one side and settle on English [Some chance ...!].
However, turning to the crux of Signor Dompé letter, is the ?patent system itself ? creaking?? As President of the UK institution that represents 1,850 patent attorneys ? most of whom are also qualified as European patent attorneys [and many of whom certainly creak, whether the patent system does or not ...] ? I must take issue with this.Bravo, says the IPKat! But don't dismiss the language of those Avatars, says Merpel: in Na'vi the word for "novel" -- an essential ingredient of any valid patent -- is "mip", which as every good IP person knows, stands for Managing Intellectual Property.?Creaking? suggests the noisy precursor to collapse. Over the last 20 years, the patent system worldwide has been amazingly successful [which is possibly why more people are using it and why investors have not apparently lost confidence in it]. However, while Signor Dompé is right to identify major concerns, mostly they are not of ?creaking?, but of silence: the silence of nothing visible happening, of patent applications waiting for years to be processed, and in some industries, although not usually the pharmaceutical industry, being typically granted after the full product life cycle to which they are relevant.
Patent offices around the world are taking steps to address these issues (see for example [the US/UK action plan to tackle backlogs, here], and the report of the recent [FICPI] Colloquium on the Patent Backlog Crisis). It is important that Governments around the world are not deflected by other parochial concerns ? otherwise the patent system may not be worth making translations for".
Full post as published by IPKat on July 13, 2010 (boomark / email).
Child Support Survival Guide
The Child Support Enforcement System
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
AIG
and Ex Execs to pay $115 Million to Teachers Retirement System of Louisiana
Heating System Thermostats
Recalled due to Shock Hazard
Cardinal Health
Issues Class 1 Recall of Alaris System

IPRIA - How much do you know about the Patent System
A Different Patent Law Proposal: U.S. Utility Models
Peer To Patent System May Become Model For Patent Offices
Enhancing The Patent System in Europe: Progress Achived So Far.
Brimelow Stresses Need For Better Patent System; Discusses Harmonisation
Never put patents in a corner!








